by Michael Dale | Apr 13, 2020 | Press Release
The scientific community is racing to bring new COVID-19 treatments to critical patients. Stem cell therapy is one of the few approaches that directly treats the lung inflammation caused by COVID-19 in these seriously ill patients in the ICU. The goal is reduction in...
by Michael Dale | Nov 26, 2019 | Press Release
Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, recently sponsored an event put on by the Arthritis Foundation and hosted by Dr. Steven Sampson and Dr. Danielle Aufiero of the Orthohealing Center in Los Angeles, California. The event,...
by Michael Dale | Nov 13, 2019 | Press Release
Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, has successfully enrolled the first patients in an FDA approved clinical trial for stem cell treatment of knee osteoarthritis. The first treatment came shortly after the one-year...
by Michael Dale | Oct 2, 2019 | Press Release
Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, has successfully enrolled the first patient in an FDA approved clinical trial for stem cell treatment of knee osteoarthritis. The successful enrollment comes only a little more than one...
by Michael Dale | Sep 24, 2019 | Press Release
Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, has completed training and site qualification for clinical trial sites and physician investigators. The clinical trial sites are now in the process of recruitment and screening of...
